Targeted therapies: Remembrance of things past - Discontinuation of second-generation TKI therapy for CML

Research output: Contribution to journalShort survey

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)201-202
Number of pages2
JournalNature Reviews Clinical Oncology
Volume14
Issue number4
DOIs
Publication statusPublished - 1 Apr 2017

ASJC Scopus subject areas

  • Oncology

Cite this